logo
Plus   Neg
Share
Email

Asahi Gets Conditional Australian Approval For Acquisition Of AB InBev Unit

Australia's competition regulator said that it will not oppose Asahi Group Holdings Ltd's proposed acquisition of Carlton & United Breweries from Anheuser-Busch InBev.
Because, Asahi agreed to divest two of its beer brands and three of its cider brands.

The Australian Competition and Consumer Commission said that the brands to be sold are the Strongbow, Bonamy's and Little Green cider brands and the Stella Artois and Beck's beer brands. The future buyer or buyers of the assets will need to be approved by the ACCC.

"The ACCC was concerned that without the divestments, the proposed acquisition would substantially lessen competition in the cider market and remove a vigorous and effective competitor in the beer market," ACCC Chair Rod Sims said.

In December 2019, the regulator raised concerns over Asahi's proposed $11 billion acquisition of Carlton & United Breweries from Anheuser-Busch InBev.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Latam Airlines Group SA, one of the largest air carrier in South America, has filed for bankruptcy protection in New York amid the ongoing Covid-19 pandemic, which has grounded flights worldwide. This Chapter 11 filing allows Latam to work with its creditors and other stakeholders to reduce its debt,... Pizza Hut said it is giving away 500,000 free pizzas to 2020 graduates in the Unites States. The pizza chain, owned by Yum! Brands, offers one free medium 1-topping pizza to all diploma/degree earning individuals until supplies last. The company is partnering with America's dairy farmers for the offer, which can be claimed until Thursday and redeemed until June 4. Merck & Co. Inc. on Tuesday announced deals, including an acquisition and two collaborations that will enable the U.S. drugmaker to join the race to develop coronavirus vaccines and drugs. Shares of Merck were rising almost 4 percent in the pre-market. Merck said it has agreed to acquire privately-held Themis, an Austria-based company focused on vaccines and immune-modulation therapies.
RELATED NEWS
Follow RTT